A 12-Month Open-Label Extension Study of the Safety and Tolerability of Lisdexamfetamine Dimesylate for Major Depressive Disorder in Adults
暂无分享,去创建一个
R. McIntyre | O. Brawman‐Mintzer | R. Weisler | D. Iosifescu | E. Sarkis | R. Mago | M. Dauphin | J. Gu | Cynthia Richards | M. Madhoo | B. Geibel